Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CIGNA CORPORATION

(CI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cigna : BofA Securities Double-Downgrades Cigna to Underperform From Buy, Lowers PT to $225 From $240, Shares Lower Premarket

09/10/2021 | 08:29am EDT


© MT Newswires 2021
All news about CIGNA CORPORATION
10/20Cigna Corporation Adds Iora Primary Care to Medicare Advantage Network in Phoenix Area
CI
10/19Cigna Appoints Lindy Hinman to Lead its Medicare Advantage Plans in Oregon and Washingt..
CI
10/19Cigna Expands its Medicare Business to Portland, Offering Medicare Advantage Plans in S..
CI
10/12WALL STREET STOCK EXCHANGE : It's just a period of market normalization
10/12ANALYST RECOMMENDATIONS : Cigna, Halliburton, Nike, Nio, Trex...
10/11AM BEST : Places Credit Ratings of Cigna Life Insurance New Zealand Limited Under Review W..
BU
10/11AM BEST : Comments on Credit Ratings of Cigna Corporation Following Asia-Pacific Business ..
BU
10/11CIGNA : UBS Adjusts Price Target on Cigna to $244 From $285, Maintains Buy Rating
MT
10/11CIGNA : AM Best Comments on Credit Ratings of Chubb Ltd and Subsidiaries Following Announc..
AQ
10/08Financial Stocks Slip Premarket Friday
MT
More news
Analyst Recommendations on CIGNA CORPORATION
More recommendations
Financials (USD)
Sales 2021 171 B - -
Net income 2021 5 356 M - -
Net Debt 2021 27 016 M - -
P/E ratio 2021 13,9x
Yield 2021 1,85%
Capitalization 73 599 M 73 599 M -
EV / Sales 2021 0,59x
EV / Sales 2022 0,54x
Nbr of Employees 72 963
Free-Float 85,4%
Chart CIGNA CORPORATION
Duration : Period :
Cigna Corporation Technical Analysis Chart | CI | US1255231003 | MarketScreener
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 216,40 $
Average target price 260,50 $
Spread / Average Target 20,4%
EPS Revisions
Managers and Directors
David Michael Cordani President, Chief Executive Officer & Director
Brian C. Evanko Chief Financial Officer & Executive Vice President
Isaiah Harris Independent Chairman
Steven B. Miller Chief Clinical Officer & Executive Vice President
Noelle K. Eder Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
CIGNA CORPORATION3.87%73 599
UNITEDHEALTH GROUP26.12%423 521
ANTHEM, INC.34.05%105 178
HUMANA INC.12.32%59 350
CENTENE CORPORATION15.34%40 370
MOLINA HEALTHCARE, INC.40.06%17 397